Literature DB >> 27780332

A Cohort Study of Mortality in Individuals With and Without Schizophrenia After Diagnosis of Lung Cancer.

Daniel W Bradford1,2,3, Joseph Goulet4,5, Marcia Hunt6,5, Natasha C Cunningham3, Rani Hoff6,5.   

Abstract

OBJECTIVE: Individuals with serious mental illness have increased mortality relative to those without these illnesses. Although cancer is a leading cause of death, few studies have evaluated potential disparities relative to mortality for individuals with serious mental illness who are diagnosed with cancer. In this study, we evaluated mortality after diagnosis of a common malignancy (lung cancer) in a prototypical serious mental illness (schizophrenia).
METHODS: Using administrative data in the Veterans Affairs system, we identified 34,664 individuals who were diagnosed with lung cancer between October 1, 2001, and September 30, 2005. We conducted a survival analysis comparing individuals with and without ICD-9-CM schizophrenia using data through September 30, 2010. Controlling variables were age, gender, smoking status, marital status, service connection, homelessness status, and presence of a substance use disorder.
RESULTS: Our results demonstrated significantly poorer survival after lung cancer diagnosis for individuals with schizophrenia compared to those without schizophrenia. The hazard ratio for all-cause mortality associated with schizophrenia was 1.33 (95% CI, 1.22-1.44).
CONCLUSIONS: Individuals with schizophrenia are at higher risk of death after diagnosis of lung cancer than those without schizophrenia. Future studies should further characterize cause of death, quality of cancer care received, and barriers to care. © Copyright 2016 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27780332     DOI: 10.4088/JCP.15m10281

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  2 in total

1.  Mortality from cancer in people with severe mental disorders in Emilia Romagna Region, Italy.

Authors:  Luigi Grassi; Elisa Stivanello; Martino Belvederi Murri; Vincenza Perlangeli; Paolo Pandolfi; Fabio Carnevali; Rosangela Caruso; Alessio Saponaro; Mila Ferri; Michele Sanza; Angelo Fioritti; Elena Meggiolaro; Federica Ruffilli; Maria Giulia Nanni; Maria Ferrara; Paola Carozza; Luigi Zerbinati; Tommaso Toffanin; Marco Menchetti; Domenico Berardi
Journal:  Psychooncology       Date:  2021-09-09       Impact factor: 3.955

2.  Case report: Schizophrenia and hypertrophic osteoarthropathy, a rare syndrome hiding a life-threatening condition.

Authors:  Emna Baklouti; Mehdi Karoui; Rania Kammoun; Faten Ellouze
Journal:  Clin Case Rep       Date:  2022-01-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.